Abrysvo 120 μg Injection
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of respiratory syncytial virus (RSV) infection in high-risk infants and young children.
Dosage (summary)
Administer 120 μg as a single dose via intramuscular injection.
Onset of Action / Duration
Immunity develops within 2 to 4 weeks after vaccination.
Special Populations
- Infants under 6 months of age
- Children with underlying health conditions
- Immunocompromised patients
Pregnancy & Breastfeeding
Safety during pregnancy and lactation has not been established; use only if clearly needed.
Key Drug Interactions
- Immunosuppressive therapies may reduce vaccine efficacy.
- Concurrent administration with other vaccines should be evaluated.
Contraindications
- Severe allergic reaction to any component of the vaccine.
- History of anaphylaxis to previous RSV vaccines.
Common side effects
- Injection site reactions (pain, redness, swelling)
- Fever
- Fatigue
- Headache
- Nausea
Counselling Points
- Inform patients about the importance of vaccination in preventing RSV.
- Advise on potential side effects and when to seek medical attention.
- Encourage reporting of any adverse reactions post-vaccination.
Serious warnings
- Monitor for allergic reactions post-injection.
- Not intended for treatment of active RSV infection.
- Consult healthcare provider if symptoms persist or worsen.
Important Disclaimer
The Abrysvo 120 μg Injection professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
